Back
Pliant Therapeutics Stock Price Chart
Sponsored
PLRX
Sponsored
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report
Sell
11
PLRX
Pliant Therapeutics
Last Price:
14.89
Seasonality Move:
-12.02%
7 Day Trial
ALL ACCESS PASS
$
7
S&P Global: Private Equity Invests $36 Billion Into What?
Read More- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.64 | Sell |
20-day SMA: | 15.21 | Sell |
50-day SMA: | 16.22 | Sell |
200-day SMA: | 16.69 | Sell |
8-day EMA: | 14.65 | Sell |
20-day EMA: | 15.14 | Sell |
50-day EMA: | 15.8 | Sell |
200-day EMA: | 17.22 | Sell |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 42.19 | Sell |
Chaikin Money Flow: | 23808 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.65 - 16.31) | Sell |
Bollinger Bands (100): | (14.47 - 17.55) | Sell |
Pliant Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.54 while PLRX 8-day simple moving average is 14.64, which is a Sell signal.
- The stock price of PLRX is 14.54 while Pliant Therapeutics 20-day SMA is 15.21, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 16.22 while PLRX share price is 14.54, making it a Sell technically.
- PLRX stock price is 14.54 and Pliant Therapeutics 200-day simple moving average is 16.69, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
11
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $14.54. The Score for PLRX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
875.88M
Price in USD:
14.54
Share Volume:
208.98K
Pliant Therapeutics 52-Week Range
52-Week High:
30.85
52-Week Low:
12.61
Sell
11
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 14.54 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 14.54 while PLRX 8-day exponential moving average is 14.65, which is a Sell signal.
- The stock price of PLRX is 14.54 while Pliant Therapeutics 20-day EMA is 15.14, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 15.80 while PLRX share price is 14.54, making it a Sell technically.
- PLRX stock price is 14.54 and Pliant Therapeutics 200-day simple moving average is 17.22, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is -0.52, suggesting Pliant Therapeutics is a Sell
- Pliant Therapeutics Relative Strength Index (RSI) is 42.19, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (14.65 - 16.31), which suggest Pliant Therapeutics is a Sell
- The Bollinger Bands (100) for Pliant Therapeutics is (14.47 - 17.55), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.